Bioanalysis Zone

Learn practical approaches for measuring all components of your molecule from scientific experts in this live 45-minute webinar and Q&A. Explore more here >>> hubs.ly/Q044DTYR0

Nominations for the 2026 Bioanalysis Rising Star Award have officially closed. Thank you to everyone who nominated! Stay tuned for the shortlisted finalists… In the meantime, you can find out more about the award from our 2025 winner: hubs.ly/Q03-XnVl0

🛋️📖 We're back with a new journal reading list, this time with the top six most read articles from Bioanalysis in 2025! Explore updated European Bioanalysis Forum recommendations, a commentary on FDA biomarker validation gaps, and the rising public health threat of xylazine and medetomidine in illicit drug supplies. A question to mull over while you read: Where do you side in these impactful discussions? hubs.ly/Q046k-8z0

Are you interested in overcoming challenges for preclinical bioanalysis of ADC therapeutics? Register for our upcoming webinar now >>> hubs.ly/Q047GMyg0

We’re kicking off 2026 by putting flow cytometry in the spotlight, in partnership with @ICONplc! Explore recent industry advancements and discover how strategic partnerships and cutting-edge tech are transforming biomarker analysis and driving innovation >>> hubs.ly/Q03-XJgB0

From automated rare event detection to AI-driven analytics, innovations in flow cytometry are transforming bioanalysis. Explore emerging technologies and global trends, backed by survey data from your peers in the bioanalytical field. Download the infographic >>> hubs.ly/Q046GLvQ0 This infographic is sponsored by @ICONplc

By emphasizing innovation, standardization and collaboration, this Panel discussion aims to highlight the drivers shaping the future of bioanalytical flow cytometry and its impact on assay development, validation and clinical trial execution. Register now >>> hubs.ly/Q044pXTn0 @ICONplc

Compare the analytical ranges and sensitivities of PCR techniques with Katherine Veirs, Group Leader of TLM at @QPSHoldingsLLC! This video interview highlights the technical differences between qPCR, dPCR and ddPCR and the best-use case for each. Watch now >>> hubs.ly/Q0448xY80

Did you miss the latest #webinar? Watch on demand to learn more about optimal #workflows for ADC quantitation and more today >>> hubs.ly/Q042Qb8y0

A portable ‘world-first’ diagnostic test can detect four common sexually transmitted infections (STIs) in under an hour, potentially transforming testing access and treatment, especially in communities where laboratory services are limited. Read the full story: hubs.ly/Q0477D4Z0

Learn about the future of microsampling within in this #webinar with James Tunaley and Alexandra Bushby, both from @Labcorp. Register to join the discussion >>> hubs.ly/Q045mLyv0

Part two of the ‘PCR-based methods for gene therapy bioanalysis’ series is now available! Catch up with @QPSHoldingsLLC’s Katherine Veirs and discover PCR applications in gene therapy. Watch now >>> hubs.ly/Q046THtL0

Have you registered for our upcoming webinar: ‘LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics’? Explore more here>>> hubs.ly/Q044DRC20

What is the FDA’s Final CSA Guidance and what this means for the pharmaceutical industry? What’s changed from the old CSV approach? In this interview we sit down with Nick Vickers, a specialist in Computer Systems Validation with over 30 years of experience, to gain a clear understanding of the FDA’s Final Computer Software Assurance (CSA) Guidance and what it means for the pharmaceutical industry, including: - How the CSA Guidance differs from traditional Computer System Validation (CSV) - How CSA aligns with global bioanalytical regulatory requirements, including the ICH and EMA - Application of CSA to emerging technologies like AI - Practical strategies for implementing CSA, even in legacy systems - Challenges and gaps in the Guidance Get a rundown here: hubs.ly/Q046Tnp00

This article introduces FALCON-qPCR (Fpg-assisted Long-PCR), a streamlined, high-sensitivity method for quantifying oxidative damage in mtDNA. By integrating enzymatic lesion recognition with quantitative amplification in a unified workflow, FALCON-qPCR eliminates the need for mitochondrial isolation, providing a rapid, accurate and scalable platform for studying oxidative DNA damage, with broad applicability in mitochondrial research and translational toxicology. Dive into the method here: hubs.ly/Q046GKR90

5 days left to nominate a young bioanalytical scientist for the 2025 Bioanalysis Rising Star Award! ⭐🏆 Nominate here >>> hubs.ly/Q03-XlCv0

@rapidnovor has received a provisional license from the Ontario Ministry of Health for its @easym_test, a personalized, non-invasive blood test designed to track measurable residual disease for multiple myeloma. Find out more about Rapid Novor’s proprietary mass spectrometry-based protein sequencing technology ➡️ hubs.ly/Q046MR3K0

Infographic: Bioanalytical flow cytometry Discover more about common challenges like instrument variability and harmonizing global workflows. Download now >>> hubs.ly/Q046GH8s0 This infographic is sponsored by @ICONplc

A new antibody test has been validated for mpox during an outbreak in Rwanda, offering health authorities a practical way to track infection and guide vaccination strategies in real time. "We remain fully committed to building capacity for managing future outbreaks of infectious disease and we are very grateful to members of the Rwanda public especially who supported this research. It is critical that science is developed in the settings and populations that reflect the need. This is a meaningful step forward to improve global health security and is a real-world demonstration of research in action,” commented Christopher Green, a Consultant Physician in Infectious Diseases at University Hospitals Birmingham NHS Trust and Chief Investigator of the MpoxCARE project. Find out more here: hubs.ly/Q046B0xw0

A team from @GeorgiaTech have introduced a drug delivery system that targets tumors and spares healthy tissue. Dubbed SANGs, AKA "self-assembling nanohydrogels", these gel-like particles circulate throughout the body and release their drugs only in response to tumor-specific conditions. hubs.ly/Q046kN960